Source: Virtual Congress 2021 – Pharmacology of airway diseases: clinical and laboratory studies



Rating:

Share or cite this content

Citations should be made in the following way:
S. Tillgren (Lund, Sweden), J. Nieto Fontarigo (Lund, Sweden), S. Cerps (Lund, Sweden), M. Hvidtfeldt (Copenhagen, Denmark), A. Sverrild (Copenhagen, Denmark), C. Porsbjerg (Copenhagen, Denmark), L. Uller (Lund, Sweden). Imiquimod shows anti-viral actions in human bronchial epithelium - implications for COVID-19 treatment. 2136

Member's Comments

No comment yet.

Related content which might interest you: Azithromycin induces anti-viral responses in bronchial epithelial cells Source: Eur Respir J 2010; 36: 646-654 Year: 2010 Viral mimic poly-(I:C) attenuates airway epithelial T-cell suppressive capacity: implications for asthma Source: Eur Respir J 2016; 48: 1785-1788 Year: 2016 The antiinflammatory effect of statins on human bronchial epithelial cells Source: Annual Congress 2008 - Airway cell biology Year: 2008 The antiinflammatory effect of statins on human bronchial epithelial cells Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 Anticholinergic treatment does not affect toll-like receptor 3-induced antiviral immune response in COPD bronchial epithelial cells Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 A novel short isoform of ACE2 is expressed in ciliated airway epithelium and is induced by interferon and rhinovirus infection but not SARS-COV-2; implications for COVID-19 interferon treatment Source: Virtual Congress 2021 – Emerging respiratory diseases: state-of-the-art studies of SARS-CoV-2 infection Year: 2021 Role of altered immune response in CF and implication for antiinflammatory therapies Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease Year: 2012 Late Breaking Abstract - Anti-inflammatory and anti-fibrotic effect of novel, pan-PDE inhibitors in human bronchial epithelial cells Source: Virtual Congress 2020 – Scientific advances in airway pharmacology Year: 2020 Anti-inflammatory efficacy of formoterol via transrepressive mechanisms is independent of the glucocorticoid receptor in human bronchial epithelial cells Source: Eur Respir J 2004; 24: Suppl. 48, 128s Year: 2004 The effect of Taxane anticancer drugs on bronchiolar ciliary activity in human airway cultured cells Source: Virtual Congress 2020 – Respiratory homeostasis and structural changes in disease Year: 2020 Lipopolysacharide modulates glucocorticoid receptor function in nasal mucosa and polyp fibroblasts Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 TGFβ1 induced loss of β-adrenergic response in human bronchial smooth muscle cells (hBSMC) is dependent on TGFβ-RI kinase activity: potential therapeutic application in treating airway diseases Source: Annual Congress 2003 - Mechanisms of lung injury: from bench to bedside Year: 2003 TD-0903, an inhaled JAK inhibitor in development for COVID-19, blocks ARDS-relevant hyperinflammation and lung injury in primary human immune and airway epithelial cells Source: Virtual Congress 2021 – Emerging respiratory diseases: state-of-the-art studies of SARS-CoV-2 infection Year: 2021 Inflammatory and antioxidant effects of inhaled nanoparticles on human primary bronchial epithelial cells Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling Year: 2019 Inhibition of phosphodiesterase 4B enhances glucocorticoid-dependent gene transcription in human airway epithelial cells: Implications for the treatment of COPD Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells Source: Eur Respir J 2012; 39: 439-445 Year: 2012 Differential effects of budesonide and fluticasone propionate on immune defense genes in human bronchial epithelium Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells Source: Eur Respir J 2015; 45: 428-439 Year: 2015 Combining an epithelial repair factor and anti-fibrotic with a corticosteroid offers optimal treatment for the pathogenesis of allergic airways disease Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016